Conversely, some authors suggest that HHL should be avoided in the presence of BC or other estrogen-dependent cancers, as phytoestrogens (especially 8-prenylnaringenin and 6-prenylnaringenin) act as agonists on both ER-α and ER-β [80,81]. Here, ESR2 is linked to breast cancer.